Colorado Capitol Watch


Welcome Visitor

Forgot password?
Subscribe for Current Session

My CCW Tools

Look Up Bills

Look Up Legislators

Legislative Year: 2022 Change

Bill Detail: HB22-1344

Return to list of bills

emailSend an email to your legislator

Title FDA-approved Prescription 3,4-Methylenedioxymethamphetamine Drug Use
Status Signed by the President of the Senate (05/31/2022)
Bill Subjects
  • Health Care & Health Insurance
House Sponsors P. Neville (R)
D. Ortiz (D)
Senate Sponsors J. Ginal (D)
J. Cooke (R)
House Committee Public and Behavioral Health & Human Services
Senate Committee Health and Human Services
Date Introduced 03/28/2022

The bill states that if the United States food and drug
administration approves a prescription medicine that contains
3,4-methylenedioxymethamphetamine (MDMA), and if that medicine has

been placed on a schedule of the federal Controlled Substances Act,
other than schedule I, or has been exempted from one or more provisions
of such act, then thereafter prescribing, dispensing, transporting,
possessing, and using that prescription drug is legal in Colorado.

Committee Reports
with Amendments
Full Text
Full Text of Bill (pdf) (most recent)
Fiscal Notes Fiscal Notes (04/01/2022) (most recent)  
Additional Bill Documents Bill Documents
  • Past bill versions
  • Past fiscal notes
  • Committee activity and documents
  • Bill History
Lobbyists Lobbyists
Audio [This feature is available by subscription.]  
Votes House and Senate Votes
Vote Totals Vote Totals by Party
border   border
Copyright © 2008-2022 State Capitol Watch